Parkman Healthcare Partners as of March 31, 2020
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 66 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Merck & Co (MRK) | 7.7 | $17M | 216k | 76.94 | |
Neurocrine Biosciences (NBIX) | 5.2 | $11M | 129k | 86.55 | |
Gw Pharmaceuticals Plc ads | 5.0 | $11M | 123k | 87.57 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.7 | $10M | 43k | 237.94 | |
UnitedHealth (UNH) | 4.0 | $8.7M | 35k | 249.37 | |
Dex (DXCM) | 4.0 | $8.6M | 32k | 269.28 | |
Horizon Therapeutics | 3.4 | $7.3M | 247k | 29.62 | |
Xenon Pharmaceuticals (XENE) | 3.1 | $6.7M | 590k | 11.34 | |
Axonics Modulation Technolog (AXNX) | 2.8 | $6.1M | 242k | 25.41 | |
Dicerna Pharmaceuticals | 2.6 | $5.5M | 301k | 18.37 | |
Icad (ICAD) | 2.5 | $5.3M | 726k | 7.34 | |
Momenta Pharmaceuticals | 2.2 | $4.8M | 176k | 27.20 | |
Avrobio Ord (AVRO) | 2.1 | $4.6M | 296k | 15.56 | |
Molecular Templates | 2.1 | $4.6M | 343k | 13.29 | |
Intuitive Surgical (ISRG) | 2.1 | $4.5M | 9.1k | 495.26 | |
Repro-Med Systems (KRMD) | 2.0 | $4.3M | 572k | 7.50 | |
Silk Road Medical Inc Common (SILK) | 2.0 | $4.3M | 135k | 31.48 | |
Karyopharm Therapeutics (KPTI) | 1.9 | $4.1M | 216k | 19.21 | |
Seattle Genetics | 1.9 | $4.1M | 35k | 115.38 | |
Eidos Therapeutics | 1.8 | $4.0M | 81k | 48.99 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $4.0M | 36k | 108.85 | |
Turning Point Therapeutics I | 1.7 | $3.6M | 80k | 44.66 | |
Schrodinger (SDGR) | 1.6 | $3.5M | 80k | 43.12 | |
Acceleron Pharma | 1.6 | $3.4M | 38k | 89.87 | |
Iqvia Holdings (IQV) | 1.5 | $3.2M | 30k | 107.87 | |
Itamar Med | 1.5 | $3.1M | 266k | 11.78 | |
Kodiak Sciences (KOD) | 1.4 | $3.1M | 65k | 47.70 | |
Vericel (VCEL) | 1.4 | $3.0M | 330k | 9.17 | |
Natera (NTRA) | 1.2 | $2.5M | 85k | 29.86 | |
Nuance Communications | 1.2 | $2.5M | 150k | 16.78 | |
Iradimed (IRMD) | 1.1 | $2.4M | 114k | 21.35 | |
Moderna (MRNA) | 1.0 | $2.2M | 75k | 29.95 | |
Bridgebio Pharma (BBIO) | 1.0 | $2.2M | 75k | 29.00 | |
Sage Therapeutics (SAGE) | 1.0 | $2.2M | 75k | 28.72 | |
Seaspine Holdings | 0.9 | $2.0M | 246k | 8.17 | |
Madrigal Pharmaceuticals (MDGL) | 0.9 | $2.0M | 30k | 66.77 | |
BioCryst Pharmaceuticals (BCRX) | 0.9 | $2.0M | 996k | 2.00 | |
Kala Pharmaceuticals | 0.9 | $2.0M | 225k | 8.79 | |
Stereotaxis (STXS) | 0.9 | $2.0M | 654k | 3.02 | |
Intersect Ent | 0.9 | $2.0M | 166k | 11.85 | |
Aurinia Pharmaceuticals (AUPH) | 0.8 | $1.7M | 120k | 14.51 | |
Trillium Therapeutics, Inc. Cmn | 0.8 | $1.7M | 425k | 4.04 | |
Meiragtx Holdings (MGTX) | 0.8 | $1.7M | 125k | 13.44 | |
Aclaris Therapeutics (ACRS) | 0.7 | $1.6M | 1.5M | 1.04 | |
Nephros (NEPH) | 0.7 | $1.6M | 251k | 6.30 | |
Haemonetics Corporation (HAE) | 0.7 | $1.5M | 15k | 99.69 | |
InfuSystem Holdings (INFU) | 0.7 | $1.4M | 171k | 8.49 | |
Misonix | 0.7 | $1.4M | 150k | 9.42 | |
Alphatec Holdings (ATEC) | 0.6 | $1.3M | 377k | 3.45 | |
Inspire Med Sys (INSP) | 0.6 | $1.2M | 20k | 60.30 | |
Pieris Pharmaceuticals (PIRS) | 0.5 | $1.1M | 499k | 2.28 | |
Menlo Therapeutics | 0.5 | $1.1M | 406k | 2.68 | |
Aprea Therapeutics | 0.5 | $1.0M | 30k | 34.76 | |
Catalyst Biosciences | 0.4 | $941k | 215k | 4.37 | |
Mannkind (MNKD) | 0.4 | $928k | 901k | 1.03 | |
Halozyme Therapeutics (HALO) | 0.4 | $908k | 51k | 17.99 | |
GenMark Diagnostics | 0.4 | $824k | 200k | 4.12 | |
Mustang Bio | 0.4 | $813k | 303k | 2.68 | |
R1 Rcm | 0.4 | $786k | 87k | 9.09 | |
Reata Pharmaceuticals Inc Cl A | 0.3 | $726k | 5.0k | 144.42 | |
Catabasis Pharmaceuticals Ord | 0.3 | $645k | 156k | 4.15 | |
Immunovant (IMVT) | 0.3 | $625k | 40k | 15.58 | |
D Fluidigm Corp Del (LAB) | 0.3 | $572k | 225k | 2.54 | |
Amarin Corporation (AMRN) | 0.1 | $304k | 76k | 3.99 | |
Apyx Medical Corporation (APYX) | 0.1 | $127k | 36k | 3.58 | |
Clearpoint Neuro (CLPT) | 0.0 | $90k | 25k | 3.59 |